Amedeo Smart

Free Medical Literature Service


 

Amedeo

Lung Cancer

  Free Subscription

Articles published in
Ann Surg Oncol
    April 2024
  1. SARVESTANI AL, Lambdin J, Hu M, Cabanillas M, et al
    Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers.
    Ann Surg Oncol. 2024;31:2202-2203.
    >> Share

  2. CHATTERJEE A, Kusamura S, Baratti D, Guaglio M, et al
    ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC.
    Ann Surg Oncol. 2024;31:2511-2512.
    >> Share

  3. SHIKANAI S, Yamada N, Yanagawa N, Sugai M, et al
    ASO Visual Abstract: Prognostic Impact of Tumor-Associated Macrophage-Related Markers in Patients with Adenocarcinoma of the Lung.
    Ann Surg Oncol. 2024;31:2521-2522.
    >> Share

    March 2024
  4. GRENDA TR
    Refocusing the Prognosis Lens: Conditional Survival After Surgery in Limited-Stage Small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Mar 21. doi: 10.1245/s10434-024-15168.
    >> Share

  5. PARK S, Choe J, Lee SM, Choi S, et al
    ASO Visual Abstract: Surgical Outcomes in Non-small Cell Lung Cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis.
    Ann Surg Oncol. 2024 Mar 14. doi: 10.1245/s10434-024-15135.
    >> Share

  6. LIN MW, Chen LW, Yang SM, Hsieh MS, et al
    ASO Visual Abstract: CT-Based Deep Learning Model for Spread Through Air Spaces Prediction in Ground-Glass Predominant Lung Adenocarcinoma.
    Ann Surg Oncol. 2024;31:1597-1598.
    >> Share

  7. YOON DW, Hwang S, Hong TH, Choi YL, et al
    ASO Visual Abstract: Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread.
    Ann Surg Oncol. 2024;31:1591-1592.
    >> Share

  8. PAN H, Huang J, Luo Q
    ASO Author Reflections: Should We Prefer Robotic over Thoracoscopic Surgery for Sublobar Resection in Octogenarians with Pulmonary Nodules
    Ann Surg Oncol. 2024;31:1585-1586.
    >> Share

  9. LIN MW, Chen LW, Yang SM, Hsieh MS, et al
    CT-Based Deep-Learning Model for Spread-Through-Air-Spaces Prediction in Ground Glass-Predominant Lung Adenocarcinoma.
    Ann Surg Oncol. 2024;31:1536-1545.
    >> Share

    February 2024
  10. LIN JP, Liu SY, Wang F
    ASO Author Reflections: Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After Surgery-A National Real-World Cohort Study.
    Ann Surg Oncol. 2024 Feb 23. doi: 10.1245/s10434-024-15062.
    >> Share

  11. PARK S, Choe J, Lee SM, Choi S, et al
    Surgical Outcomes in Non-Small Cell Lung Cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis.
    Ann Surg Oncol. 2024 Feb 22. doi: 10.1245/s10434-024-14984.
    >> Share

  12. LIN JP, Chen XF, Wang P, He H, et al
    Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After Surgery: A National Real-World Cohort Study.
    Ann Surg Oncol. 2024 Feb 9. doi: 10.1245/s10434-024-14983.
    >> Share

  13. XU SJ, Chen C, Tu JH, You CX, et al
    ASO Visual Abstract: Dynamic Analysis of the Impact of Micropapillary Component on Different Recurrence Patterns of Pathological Stage IA3 Lung Adenocarcinoma-A Multicenter, Retrospective Study.
    Ann Surg Oncol. 2024;31:906-907.
    >> Share

  14. XU SJ, Chen C, Tu JH, You CX, et al
    Dynamic Analysis of the Impact of Micropapillary Component on Different Recurrence Patterns of Pathological Stage IA3 Lung Adenocarcinoma: A Multicenter, Retrospective Study.
    Ann Surg Oncol. 2024;31:872-882.
    >> Share

    January 2024
  15. KAZZI B, Mankuzhy NP, Swami N, Jain B, et al
    Surgical Resection Delays among Patients with Stage 1 Lung Cancer: A Study with Disaggregated Ethnic Groups.
    Ann Surg Oncol. 2024 Jan 28. doi: 10.1245/s10434-024-14952.
    >> Share

  16. OKUYAMA A, Mizutani T, Tachibana K, Higashi T, et al
    ASO Visual Abstract: Treatment Patterns and Postoperative Activities of Daily Living in Patients with Non-small Cell Lung Cancer-A Retrospective Study Using Nationwide Health Services Utilization Data in Japan.
    Ann Surg Oncol. 2024 Jan 24. doi: 10.1245/s10434-024-14928.
    >> Share

  17. CHATTERJEE A, Kusamura S, Baratti D, Guaglio M, et al
    Impact of Perioperative Systemic Chemotherapy on Survival for Patients Who have Diffuse Malignant Peritoneal Mesothelioma Treated with CRS-HIPEC.
    Ann Surg Oncol. 2024;31:556-566.
    >> Share

  18. LI W, Yang Y, Yang M, Song N, et al
    Clinicopathologic Features and Survival Outcomes of Primary Lung Mucinous Adenocarcinoma Based on Different Radiologic Subtypes.
    Ann Surg Oncol. 2024;31:167-177.
    >> Share

  19. WOODARD GA, Cho C, Chen L
    Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis?
    Ann Surg Oncol. 2024;31:25-27.
    >> Share

  20. YANG X, Xiao Y, Hu H, Qiu ZB, et al
    ASO Visual Abstract: Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules-A Large Study of 2022 Cases in China.
    Ann Surg Oncol. 2024;31:245-246.
    >> Share

  21. YOON DW, Hwang S, Hong TH, Choi YL, et al
    Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread.
    Ann Surg Oncol. 2024;31:201-212.
    >> Share

    December 2023
  22. MI J, Li C, Yang F, Shi X, et al
    ASO Visual Abstract: Comparative Study of Indocyanine Green Fluorescence Imaging in Lung Cancer with Near-Infrared-I/II Windows.
    Ann Surg Oncol. 2023 Dec 26. doi: 10.1245/s10434-023-14795.
    >> Share

  23. PAN H, Zou N, Tian Y, Shen Y, et al
    ASO Visual Abstract: Robotic Versus Thoracoscopic Sub-lobar Resection for Octogenarians with Clinical IA-Stage Non-small Cell Lung Cancer: A Propensity Score-Matched Real-World Study.
    Ann Surg Oncol. 2023 Dec 22. doi: 10.1245/s10434-023-14799.
    >> Share

  24. OKUYAMA A, Mizutani T, Tachibana K, Higashi T, et al
    Treatment Patterns and Postoperative Activities of Daily Living in Patients with Non-small Cell Lung Cancer: A Retrospective Study Using Nationwide Health Services Utilization Data in Japan.
    Ann Surg Oncol. 2023 Dec 21. doi: 10.1245/s10434-023-14798.
    >> Share

  25. DIAO H, Xu L, Li X, Wang Y, et al
    Comparison Results of Three-Port Robot-Assisted and Uniportal Video-Assisted Lobectomy for Functional Recovery Index in the Treatment of Early Stage Non-small Cell Lung Cancer: A Propensity Score-Matched Analysis.
    Ann Surg Oncol. 2023 Dec 17. doi: 10.1245/s10434-023-14767.
    >> Share

  26. PAN H, Zou N, Tian Y, Shen Y, et al
    Robotic Versus Thoracoscopic Sub-lobar Resection for Octogenarians with Clinical Stage IA Non-small Cell Lung Cancer: A Propensity Score-Matched Real-World Study.
    Ann Surg Oncol. 2023 Dec 10. doi: 10.1245/s10434-023-14689.
    >> Share

  27. MI J, Li C, Yang F, Shi X, et al
    Comparative Study of Indocyanine Green Fluorescence Imaging in Lung Cancer with Near-Infrared-I/II Windows.
    Ann Surg Oncol. 2023 Dec 8. doi: 10.1245/s10434-023-14677.
    >> Share

  28. KINOSHITA F, Takada K, Wakasu S, Saito S, et al
    ASO Visual Abstract: Granzyme B (GZMB)-Positive Tumor-Infiltrating Lymphocytes in Lung Adenocarcinoma: Significance as a Prognostic Factor and Association With Immunosuppressive Proteins.
    Ann Surg Oncol. 2023;30:8290-8291.
    >> Share

    November 2023
  29. MACHADO PFA, Oliveiros B, Martins RA, Cruz J, et al
    ASO Author Reflections: Impact of a Preoperative Home-Based Exercise Program on Quality of Life After Lung Cancer Resection.
    Ann Surg Oncol. 2023 Nov 19. doi: 10.1245/s10434-023-14620.
    >> Share

  30. MACHADO PFA, Pimenta S, Garcia AL, Nogueira T, et al
    ASO Visual Abstract: Effect of Preoperative Home-Based Exercise Training on Quality of Life After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial.
    Ann Surg Oncol. 2023 Nov 17. doi: 10.1245/s10434-023-14602.
    >> Share

  31. MACHADO P, Pimenta S, Garcia AL, Nogueira T, et al
    Effect of Preoperative Home-Based Exercise Training on Quality of Life After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial.
    Ann Surg Oncol. 2023 Nov 7. doi: 10.1245/s10434-023-14503.
    >> Share

  32. YANG X, Xiao Y, Hu H, Qiu ZB, et al
    Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules: A Large Study of 2022 Cases in China.
    Ann Surg Oncol. 2023;30:7400-7411.
    >> Share

  33. KEPENEKIAN V, Sgarbura O, Marchal F, Villeneuve L, et al
    ASO Author Reflections: International Standardization of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocols-Malignant Peritoneal Mesothelioma as a Model.
    Ann Surg Oncol. 2023;30:7858-7859.
    >> Share

  34. VILLENA-VARGAS J
    Sowing the Seeds of Evasion: Lung Adenocarcinoma Plans Its Escape.
    Ann Surg Oncol. 2023;30:6972-6973.
    >> Share

  35. KEPENEKIAN V, Sgarbura O, Marchal F, Villeneuve L, et al
    2022 PSOGI Consensus on HIPEC Regimens for Peritoneal Malignancies: Diffuse Malignant Peritoneal Mesothelioma.
    Ann Surg Oncol. 2023;30:7803-7813.
    >> Share

  36. KOSAI K, Masuda T, Kitagawa A, Tobo T, et al
    Transducin Beta-Like 2 is a Potential Driver Gene that Adapts to Endoplasmic Reticulum Stress to Promote Tumor Growth of Lung Adenocarcinoma.
    Ann Surg Oncol. 2023;30:7538-7548.
    >> Share

  37. SHIKANAI S, Yamada N, Yanagawa N, Sugai M, et al
    Prognostic Impact of Tumor-Associated Macrophage-Related Markers in Patients with Adenocarcinoma of the Lung.
    Ann Surg Oncol. 2023;30:7527-7537.
    >> Share

    October 2023
  38. RUCK JM, Broderick SR
    Neoadjuvant and Adjuvant Pembrolizumab for the Treatment of Early-Stage Resectable Non-small Cell Lung Cancer An Editorial Regarding the Interim Data Analysis of the KEYNOTE-671 Phase III Trial of Neoadjuvant and Adjuvant Pembrolizumab.
    Ann Surg Oncol. 2023 Oct 26. doi: 10.1245/s10434-023-14356.
    >> Share

  39. SWANSON SJ
    Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a New Classification System-All "Segmentectomies" Are Not Created Equal.
    Ann Surg Oncol. 2023;30:6315.
    >> Share

  40. YAO F, Wu W, Zhu Q, Zhu Y, et al
    ASO Visual Abstract: Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a New Classification.
    Ann Surg Oncol. 2023;30:6717.
    >> Share

  41. ALEXANDER HR
    Perioperative Systemic Chemotherapy in Patients with Malignant Peritoneal Mesothelioma Undergoing Cytoreduction and HIPEC: Don't Put the Cart Before the Horse.
    Ann Surg Oncol. 2023;30:6301-6303.
    >> Share

  42. YAO F, Wu W, Zhu Q, Zhu Y, et al
    Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a New Classification.
    Ann Surg Oncol. 2023;30:6707-6716.
    >> Share

    September 2023
  43. MATSUDA N, Yamamoto H, Habu T, Iwata K, et al
    ASO Visual Abstract: Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
    Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14311.
    >> Share

  44. FU F, Zhang Y, Chen H
    ASO Author Reflections: Upfront Surgery Followed by Adjuvant Therapy: An Option for IIIA-N2 Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14265.
    >> Share

  45. WANG T, Zhou J, Zheng Q, Wu D, et al
    ASO Visual Abstract: A Competing Risk Model Nomogram to Predict the Long-Term Prognosis of Lung Carcinoid.
    Ann Surg Oncol. 2023;30:5842.
    >> Share

  46. WANG K, Huang W, Chen X, Li G, et al
    Efficacy of Near-Infrared Fluorescence Video-Assisted Thoracoscopic Surgery for Small Pulmonary Nodule Resection with Indocyanine Green Inhalation: A Randomized Clinical Trial.
    Ann Surg Oncol. 2023;30:5912-5922.
    >> Share

  47. XU SJ, Tu JH, Chen H, Yan RH, et al
    ASO Visual Abstract: A Multi-Institutional Study Analyzing the Combined Effect of Micropapillary Component and Consolidation-to-Tumor Ratio Exceeding 0.5 on the Prognosis for Pathologic Stage IA3 Lung Adenocarcinoma.
    Ann Surg Oncol. 2023;30:5854-5855.
    >> Share

  48. XU SJ, Tu JH, Chen H, Yan RH, et al
    A Multi-institutional Analysis of the Combined Effect of Micropapillary Component and Consolidation-to-Tumor Ratio >0.5 on the Prognosis of Pathological, Stage IA3, Lung Adenocarcinoma.
    Ann Surg Oncol. 2023;30:5843-5853.
    >> Share

  49. WANG T, Zhou J, Liu L
    ASO Author Reflections: Prediction of Long-Term Cancer-Specific Survival of Lung Carcinoid Patients.
    Ann Surg Oncol. 2023;30:5840-5841.
    >> Share

  50. WANG T, Zhou J, Zheng Q, Wu D, et al
    A Competing Risk Model Nomogram to Predict the Long-Term Prognosis of Lung Carcinoid.
    Ann Surg Oncol. 2023;30:5830-5839.
    >> Share

  51. MATSUDA N, Yamamoto H, Habu T, Iwata K, et al
    Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
    Ann Surg Oncol. 2023 Sep 1. doi: 10.1245/s10434-023-14176.
    >> Share

    August 2023
  52. MATSUDA N, Yamamoto H, Habu T, Takahashi K, et al
    ASO Author Reflections: Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio are Prognostic Factors in Pulmonary Metastases from Uterine Leiomyosarcoma.
    Ann Surg Oncol. 2023 Aug 30. doi: 10.1245/s10434-023-14199.
    >> Share

  53. FU F, Sun W, Bai J, Deng C, et al
    Long-Term Outcomes of Selected Patients with IIIA-N2 Non-small Cell Lung Cancer Receiving Upfront Surgical Resection.
    Ann Surg Oncol. 2023 Aug 30. doi: 10.1245/s10434-023-14072.
    >> Share

  54. YANG Z, Fu F, Zhang Y
    ASO Author Reflections: Long-Term Prognostic Factors for Stage IB Lung Cancer Patients: Pulmonary Groud-Glass Opacity or Visceral Pleural Invasion?
    Ann Surg Oncol. 2023 Aug 24. doi: 10.1245/s10434-023-14092.
    >> Share

  55. CHEN T, Cao Z, Sun Y, Huang J, et al
    Neoadjuvant Chemoimmunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2023 Aug 16. doi: 10.1245/s10434-023-14123.
    >> Share

  56. YANG Z, Li X, Bai J, Li D, et al
    Prognostic Factors for Survival of Stage IB Non-small Cell Lung Cancer Patients: A 10-Year Follow-Up Retrospective Study.
    Ann Surg Oncol. 2023 Aug 3. doi: 10.1245/s10434-023-14016.
    >> Share

  57. CALTHORPE L, Romero-Hernandez F, Casey M, Nunez M, et al
    ASO Visual Abstract: National Practice Patterns in Malignant Peritoneal Mesothelioma-Updates in Management and Survival.
    Ann Surg Oncol. 2023;30:5131.
    >> Share

  58. CALTHORPE L, Alseidi A, Adam MA
    ASO Author Reflections: Contemporary Management Trends in Malignant Peritoneal Mesothelioma.
    Ann Surg Oncol. 2023;30:5130.
    >> Share

  59. CALTHORPE L, Romero-Hernandez F, Casey M, Nunez M, et al
    National Practice Patterns in Malignant Peritoneal Mesothelioma: Updates in Management and Survival.
    Ann Surg Oncol. 2023;30:5119-5129.
    >> Share

    July 2023
  60. FUJIWARA T, Shien K, Matsuura M, Soh J, et al
    ASO Visual Abstract: EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After Surgery.
    Ann Surg Oncol. 2023 Jul 30. doi: 10.1245/s10434-023-14005.
    >> Share

  61. LI Z, Xu W, Wang J, Zhu Q, et al
    ASO Visual Abstract: Three-Dimensional-Guided Cone-Shaped Segmentectomy Versus Lobectomy for Small-Sized Non-small Cell Lung Cancer in the Middle Third Lung Field.
    Ann Surg Oncol. 2023 Jul 19. doi: 10.1245/s10434-023-13850.
    >> Share

  62. KALVAPUDI S, Yendamuri S
    Surgical Management of Incidentally Detected Pleural Disease in Lung Cancer Patients: A Complex Decision.
    Ann Surg Oncol. 2023 Jul 7. doi: 10.1245/s10434-023-13859.
    >> Share

  63. HONG Z, Bai X, Sheng Y, Cui B, et al
    Efficacy of Using Maryland Forceps Versus Electrocoagulation Hooks in RATS Lung Cancer Surgery: A Propensity Score-Matched Study.
    Ann Surg Oncol. 2023 Jul 2. doi: 10.1245/s10434-023-13813.
    >> Share

    June 2023
  64. TIAN JY, Hao XY, Tong L, Fu Q, et al
    ASO Author Reflections: Preoperative Frailty Assessment Predicts Postoperative Adverse Outcomes in Elderly Lung Cancer Patients: A Retrospective Cohort Study.
    Ann Surg Oncol. 2023 Jun 30. doi: 10.1245/s10434-023-13737.
    >> Share

  65. LI Z, Xu W, Wang J, Zhu Q, et al
    Three-Dimensional Guided Cone-Shaped Segmentectomy Versus Lobectomy for Small-sized Non-Small Cell Lung Cancer in the Middle Third of the Lung Field.
    Ann Surg Oncol. 2023 Jun 28. doi: 10.1245/s10434-023-13772.
    >> Share

  66. SHIEN K, Fujiwara T, Toyooka S
    ASO Author Reflections: Prognostic Impact of the Primary Tumor Resection for Lung Cancer Patients Diagnosed with Pleural Dissemination in the Perioperative Period-Importance of Biomarker-Based Treatment Decision Making.
    Ann Surg Oncol. 2023 Jun 25. doi: 10.1245/s10434-023-13808.
    >> Share

  67. FUJIWARA T, Shien K, Matsuura M, Soh J, et al
    EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After Surgery.
    Ann Surg Oncol. 2023 Jun 25. doi: 10.1245/s10434-023-13791.
    >> Share

  68. LI Z, Wu W, Chen L
    ASO Author Reflections: Three-Dimensional-Guided Segmentectomy can be an Alternative to Lobectomy for Small-Sized Non-small Cell Lung Cancer in the Middle-Third Lung Parenchyma.
    Ann Surg Oncol. 2023 Jun 22. doi: 10.1245/s10434-023-13773.
    >> Share

  69. TIAN JY, Hao XY, Cao FY, Liu JJ, et al
    Preoperative Frailty Assessment Predicts Postoperative Mortality, Delirium and Pneumonia in Elderly Lung Cancer Patients: A Retrospective Cohort Study.
    Ann Surg Oncol. 2023 Jun 16. doi: 10.1245/s10434-023-13696.
    >> Share

  70. XU S, He Z, Li X, He J, et al
    Lymph Node Metastases in Surgically Resected Solitary Ground-Glass Opacities: A Two-Center Retrospective Cohort Study and Pooled Literature Analysis.
    Ann Surg Oncol. 2023;30:3760-3768.
    >> Share

  71. MERKELY G, Leite CBG, Newman ET, Raskin K, et al
    Venous Thromboembolic Event Following Soft Tissue Sarcoma Diagnosis is Associated with the Development of Pulmonary Metastasis.
    Ann Surg Oncol. 2023;30:3692-3699.
    >> Share

    May 2023
  72. BRUNELLI A
    Segmentectomy is the Surgical Procedure of Choice for Peripheral Early-Stage Non-small Cell Lung Cancer (Most Likely!).
    Ann Surg Oncol. 2023 May 3. doi: 10.1245/s10434-023-13579.
    >> Share

  73. YANG MZ, Tan ZH, Li JB, Xie CL, et al
    ASO Visual Abstract: Comparison of Short-Term Outcomes Between Robot-Assisted and Video-Assisted Segmentectomy for Small Pulmonary Nodules-A Propensity Score Matching Study.
    Ann Surg Oncol. 2023;30:2767-2768.
    >> Share

  74. VALENZUELA CD, Solsky IB, Erali RA, Forsythe SD, et al
    ASO Visual Abstract: Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center.
    Ann Surg Oncol. 2023;30:2676-2677.
    >> Share

  75. YANG MZ, Tan ZH, Li JB, Xie CL, et al
    Comparison of Short-Term Outcomes Between Robot-Assisted and Video-Assisted Segmentectomy for Small Pulmonary Nodules: A Propensity Score-Matching Study.
    Ann Surg Oncol. 2023;30:2757-2764.
    >> Share

  76. YANG MZ, Yang HX
    ASO Author Reflections: Which Technique is Superior for Segmentectomy of Small Pulmonary Nodules: Robot-Assisted or Video-Assisted?
    Ann Surg Oncol. 2023;30:2765-2766.
    >> Share

  77. VALENZUELA CD, Solsky IB, Erali RA, Forsythe SD, et al
    Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center.
    Ann Surg Oncol. 2023;30:2666-2675.
    >> Share

    April 2023
  78. NAGANO T, Kinoshita F, Hashinokuchi A, Matsudo K, et al
    ASO Visual Abstract: Prognostic Impact of C-Reactive Protein-to-Lymphocyte Ratio in Non-small Cell Lung Cancer-A Propensity Score Matching Analysis.
    Ann Surg Oncol. 2023 Apr 8. doi: 10.1245/s10434-023-13396.
    >> Share

  79. MA H, Li S, Zhu Y, Zhang W, et al
    ASO Author Reflections: CT-Based Prognostic Score as an Indicator for Predicting the Survival of Patients with Synchronous Multiple Primary Lung Cancer.
    Ann Surg Oncol. 2023 Apr 7. doi: 10.1245/s10434-023-13420.
    >> Share

  80. RAMOS ARIAS G, Sindayigaya R, Ouaissi M, Buggisch JR, et al
    Safety and Feasibility of High-Pressure/High-Dose Pressurized Intraperitoneal Aerosol Chemotherapy (HP/HD-PIPAC) for Primary and Metastatic Peritoneal Surface Malignancies.
    Ann Surg Oncol. 2023;30:2497-2505.
    >> Share

    March 2023
  81. GONG S, Yao X
    The Combination of Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio Predicts Survival for Non-small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2023 Mar 29. doi: 10.1245/s10434-023-13379.
    >> Share

  82. CHEN KN
    Factors to Consider in Surgical Resection of Pulmonary Metastatic Carcinoma.
    Ann Surg Oncol. 2023;30:1297-1298.
    >> Share

  83. MITZMAN B
    Is Less Really More? Sublobar Resection in the Elderly.
    Ann Surg Oncol. 2023;30:1293-1294.
    >> Share

  84. ITO T, Nakamura S, Kadomatsu Y, Ueno H, et al
    ASO Visual Abstract: Impact of Pleural Thickness on the Occurrence of Postoperative Complications in Patients with Malignant Pleural Mesothelioma.
    Ann Surg Oncol. 2023;30:1586.
    >> Share

  85. NAKAMURA S, Ito T, Chen-Yoshikawa TF
    ASO Author Reflections: Pleural Thickness in Patients with Malignant Pleural Mesothelioma.
    Ann Surg Oncol. 2023;30:1584-1585.
    >> Share

  86. ITO T, Nakamura S, Kadomatsu Y, Ueno H, et al
    Impact of Pleural Thickness on Occurrence of Postoperative Complications in Patients with Malignant Pleural Mesothelioma.
    Ann Surg Oncol. 2023;30:1574-1583.
    >> Share

    February 2023
  87. NAGANO T, Kinoshita F, Hashinokuchi A, Matsudo K, et al
    Prognostic Impact of C-Reactive Protein-to-Lymphocyte Ratio in Non-small Cell Lung Cancer: A Propensity Score-Matching Analysis.
    Ann Surg Oncol. 2023 Feb 27. doi: 10.1245/s10434-023-13250.
    >> Share

  88. TANG L, Yu H, Dai W, Yang X, et al
    ASO Visual Abstract: Symptom Trajectories Informing Patient Care After Lung Cancer Surgery: A Longitudinal Patient-Reported Outcome Study.
    Ann Surg Oncol. 2023 Feb 27. doi: 10.1245/s10434-023-13209.
    >> Share

  89. MA H, Li S, Zhu Y, Zhang W, et al
    A Novel Prognostic Score Based on Multiple Quantitative Parameters of Chest CT for Patients with Synchronous Multiple Primary Lung Cancer: Is Solid Component Size a Better Prognostic Indicator?
    Ann Surg Oncol. 2023 Feb 23. doi: 10.1245/s10434-023-13248.
    >> Share

  90. YOTSUKURA M, Muraoka Y, Yoshida Y, Nakagawa K, et al
    ASO Visual Abstract: Long-Term Prognosis and Prognostic Indicators of Stage IA Lung Adenocarcinoma.
    Ann Surg Oncol. 2023;30:859-860.
    >> Share

  91. TANKEL J, Cools-Lartigue J
    Dual Image Navigation Aiding Segmentectomy for Early NSCLC: Feasible, but Useful?
    Ann Surg Oncol. 2023;30:669-671.
    >> Share

  92. SHIGEFUKU S, Ito H, Miura J, Kikuchi A, et al
    ASO Visual Abstract: Prognostic Significance of the Maximum Standardized Uptake Value on the Prognosis of Clinical Stage IA Lung Adenocarcinoma Based on the 8th Edition TNM Classification.
    Ann Surg Oncol. 2023;30:841-842.
    >> Share

  93. CHANG SS, Yokomise H, Yokota N, Yoshida C, et al
    ASO Visual Abstract: Dual Image Navigation to Secure Surgical Margins in Thoracoscopic Segmentectomy.
    Ann Surg Oncol. 2023;30:850.
    >> Share

  94. SHIGEFUKU S, Ito H, Miura J, Kikuchi A, et al
    Prognostic Significance of the Maximum Standardized Uptake Value on the Prognosis of Clinical Stage IA Lung Adenocarcinoma Based on the 8th Edition TNM Classification.
    Ann Surg Oncol. 2023;30:830-838.
    >> Share

  95. SHIGEFUKU S
    ASO Author Reflections: Is SUVmax Comparable with TNM Classification 8th Edition in Early-Stage Lung Adenocarcinoma?
    Ann Surg Oncol. 2023;30:839-840.
    >> Share

  96. YOTSUKURA M, Muraoka Y, Yoshida Y, Nakagawa K, et al
    Long-Term Prognosis and Prognostic Indicators of Stage IA Lung Adenocarcinoma.
    Ann Surg Oncol. 2023;30:851-858.
    >> Share

  97. CHANG SS, Yokomise H, Yokota N, Yoshida C, et al
    Dual Image Navigation to Secure Surgical Margins in Thoracoscopic Segmentectomy.
    Ann Surg Oncol. 2023;30:843-849.
    >> Share

    January 2023
  98. TANG L, Yu H, Dai W, Yang X, et al
    Symptom Trajectories Informing Patient Care After Lung Cancer Surgery: A Longitudinal Patient-Reported Outcome Study.
    Ann Surg Oncol. 2023 Jan 19. doi: 10.1245/s10434-022-13065.
    >> Share

  99. LI D, Deng C, Fu F, Bai J, et al
    Impact of Prior Cancer History on Outcomes of Resected Lung Cancer.
    Ann Surg Oncol. 2023 Jan 12. doi: 10.1245/s10434-022-12597.
    >> Share

  100. LI D, Deng C, Zhang Y, Chen H, et al
    ASO Author Reflections: Individualized Management of Lung Cancer Patients with a History of Cancer: Surgery or Not Requires Comprehensive Judgment.
    Ann Surg Oncol. 2023 Jan 8. doi: 10.1245/s10434-022-12634.
    >> Share

    December 2022
  101. WU S, Wang Z, Sun J, Wu H, et al
    ASO Visual Abstract: Survival Outcomes of Sublobectomy and Lobectomy in Elderly Patients with Peripheral Solid-Dominant Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Dec 30. doi: 10.1245/s10434-022-12982.
    >> Share

  102. WU S, Wu H, Chen T, Shen J, et al
    ASO Author Reflections: Survival Outcomes of Sublobectomy and Lobectomy for Elderly Patients with Peripheral Solid-Dominant Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Dec 29. doi: 10.1245/s10434-022-13015.
    >> Share

  103. WU S, Wang Z, Sun J, Wu H, et al
    Survival Outcomes of Sublobectomy and Lobectomy in Elderly Patients with Peripheral Solid-Dominant Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Dec 15. doi: 10.1245/s10434-022-12909.
    >> Share

  104. UIMONEN M, Helminen O, Bohm J, Mrena J, et al
    ASO Visual Abstract: Standard Lymphadenectomy for Esophageal and Lung Cancer: Variability in the Number of Examined Lymph Nodes Among Pathologists and Its Survival Implication.
    Ann Surg Oncol. 2022 Dec 10. doi: 10.1245/s10434-022-12886.
    >> Share

  105. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
    Correction: Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
    Ann Surg Oncol. 2022 Dec 9. doi: 10.1245/s10434-022-12931.
    >> Share

  106. TAKAMOCHI K, Tsuboi M, Okada M, Niho S, et al
    ASO Visual Abstract: S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial.
    Ann Surg Oncol. 2022;29:8209-8210.
    >> Share

  107. TAKAMOCHI K, Tsuboi M, Okada M, Niho S, et al
    S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial.
    Ann Surg Oncol. 2022;29:8198-8206.
    >> Share

    November 2022
  108. PENDLETON AC
    Commentary: The Role of PET Scan Uptake in Determining Prognosis in Early-Stage Lung Cancer.
    Ann Surg Oncol. 2022 Nov 28. doi: 10.1245/s10434-022-12687.
    >> Share

  109. UIMONEN M, Helminen O, Bohm J, Mrena J, et al
    Standard Lymphadenectomy for Esophageal and Lung Cancer: Variability in the Number of Examined Lymph Nodes Among Pathologists and Its Survival Implication.
    Ann Surg Oncol. 2022 Nov 25. doi: 10.1245/s10434-022-12826.
    >> Share

  110. USUZAKI T, Takahashi K, Ishikuro M, Obara T, et al
    Letter to the Editor: Comment on ''Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer''.
    Ann Surg Oncol. 2022 Nov 16. doi: 10.1245/s10434-022-12809.
    >> Share

  111. SHIMADA Y
    Reply to: Letter to the Editor: Comment on ''Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer'' by Usuzaki, Takuma et al.
    Ann Surg Oncol. 2022 Nov 14. doi: 10.1245/s10434-022-12822.
    >> Share

  112. COURELLI AS, Sharma AK, Madlensky L, Choi YY, et al
    ASO Visual Abstract: Co-localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series.
    Ann Surg Oncol. 2022;29:7551-7552.
    >> Share

  113. CHEN LW, Yang SM, Chuang CC, Wang HJ, et al
    ASO Visual Abstract: Solid Attenuation Components Attention Deep Learning Model to Predict Micropapillary and Solid Patterns in Lung Adenocarcinomas on Computed Tomography.
    Ann Surg Oncol. 2022;29:7483-7484.
    >> Share

  114. COURELLI AS, Sharma AK, Sicklick JK
    ASO Author Reflections: Co-Localization of Synchronous Gastrointestinal Stromal Tumors (GISTs) and Peritoneal Mesothelioma (PM): A Case Series.
    Ann Surg Oncol. 2022;29:7549-7550.
    >> Share

  115. COURELLI AS, Sharma AK, Madlensky L, Choi YY, et al
    Co-Localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series.
    Ann Surg Oncol. 2022;29:7542-7548.
    >> Share

  116. OLIVER AL, Takahashi-Pipkin C, Wong JH, Burch AE, et al
    Disparate Access to Surgery for Operable Carcinoma of the Lung in North Carolina.
    Ann Surg Oncol. 2022;29:7485-7493.
    >> Share

  117. CHEN LW, Yang SM, Chuang CC, Wang HJ, et al
    Solid Attenuation Components Attention Deep Learning Model to Predict Micropapillary and Solid Patterns in Lung Adenocarcinomas on Computed Tomography.
    Ann Surg Oncol. 2022;29:7473-7482.
    >> Share

    October 2022
  118. HERREROS-POMARES A, Doria P, Gallach S, Meri-Abad M, et al
    ASO Visual Abstract: A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2022 Oct 28. pii: 10.1245/s10434-022-12717.
    >> Share

  119. LI D, Deng C, Fu F, Bai J, et al
    ASO Visual Abstract: Impact of Prior Cancer History on Outcomes of Resected Lung Cancer.
    Ann Surg Oncol. 2022 Oct 20. pii: 10.1245/s10434-022-12658.
    >> Share

  120. BONNER SN, He C, Clark M, Adams K, et al
    ASO Visual Abstract: Understanding Racial Differences in Lung Cancer Surgery Through a Statewide Quality Collaborative.
    Ann Surg Oncol. 2022 Oct 16. pii: 10.1245/s10434-022-12546.
    >> Share

  121. GOMBODORJ N, Azuma Y, Yokobori T, Erkhem-Ochir B, et al
    RAB11A Expression Is Associated With Cancer Aggressiveness Through Regulation of FGFR-Signaling in Lung Squamous Cell Carcinoma.
    Ann Surg Oncol. 2022;29:7149-7162.
    >> Share

    September 2022
  122. SHIMADA Y, Kudo Y, Maehara S, Amemiya R, et al
    ASO Visual Abstract: Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer.
    Ann Surg Oncol. 2022 Sep 26. pii: 10.1245/s10434-022-12534.
    >> Share

  123. HERREROS-POMARES A, Doria P, Gallach S, Meri-Abad M, et al
    A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2022 Sep 21. pii: 10.1245/s10434-022-12565.
    >> Share

  124. HERREROS-POMARES A, Jantus-Lewintre E
    ASO Author Reflections: Key Components of the Hedgehog Signaling Pathway as Prognostic Biomarkers in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Sep 20. pii: 10.1245/s10434-022-12590.
    >> Share

  125. SHIMADA Y
    ASO Author Reflections: The Clinical Use of Radiomics with Artificial Intelligence in Patients with Early-Stage Lung Cancer.
    Ann Surg Oncol. 2022 Sep 13. pii: 10.1245/s10434-022-12518.
    >> Share

  126. WANG Z, Yang Z, Li S, Zhang J, et al
    ASO Visual Abstract: A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgical Resected Non-Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2022 Sep 9. pii: 10.1245/s10434-022-12413.
    >> Share

  127. TEKE ME, Saif A, Sarvestani AL, Hernandez JM, et al
    A Phase III, Randomized, Controlled Trial Comparing Open Versus Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma.
    Ann Surg Oncol. 2022 Sep 9. pii: 10.1245/s10434-022-12488.
    >> Share

  128. SHIMADA Y, Kudo Y, Maehara S, Amemiya R, et al
    Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer.
    Ann Surg Oncol. 2022 Sep 7. pii: 10.1245/s10434-022-12516.
    >> Share

  129. WANG Y, Chen Y, Yang Z, Qian F, et al
    Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma.
    Ann Surg Oncol. 2022;29:5666-5678.
    >> Share

  130. WANG Y, Han B
    ASO Author Reflections: Pure and Combined Surgically Resected Large Cell Neuroendocrine Carcinoma of Lung: Could They be Evaluated as a Single Entity?
    Ann Surg Oncol. 2022;29:5679-5680.
    >> Share

  131. KAWAKATSU S, Shimizu Y, Natsume S, Okuno M, et al
    Prognostic Significance of Intraoperative Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma: A Single-Center Experience and Systematic Review of the Literature.
    Ann Surg Oncol. 2022;29:5972-5983.
    >> Share

  132. XU W, Dai W, Gao Z, Wang XS, et al
    Establishment of Minimal Clinically Important Improvement for Patient-Reported Symptoms to Define Recovery After Video-Assisted Thoracoscopic Surgery.
    Ann Surg Oncol. 2022;29:5593-5604.
    >> Share

    August 2022
  133. BONNER SN, He C, Clark M, Adams K, et al
    Understanding Racial Differences in Lung Cancer Surgery Through a Statewide Quality Collaborative.
    Ann Surg Oncol. 2022 Aug 26. pii: 10.1245/s10434-022-12435.
    >> Share

  134. YANG Z, Wang Z, Liu L
    ASO Author Reflections: Comprehensive Comparison of N Staging Subclassification Methods for Non-Small-Cell Lung Cancer.
    Ann Surg Oncol. 2022 Aug 21. pii: 10.1245/s10434-022-12398.
    >> Share

  135. WANG Z, Yang Z, Li S, Zhang J, et al
    A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgically Resected Non-Small-Cell Lung Cancer Patients.
    Ann Surg Oncol. 2022 Aug 18. pii: 10.1245/s10434-022-12363.
    >> Share

  136. CHENG X, Zeng W, Liu Y, Song Z, et al
    ASO Visual Abstract: Impact of Lymph Node Dissection on Survival and Tumor Recurrence in Patients with Resected cT1-2N0 Small-Cell Lung Cancer.
    Ann Surg Oncol. 2022 Aug 13. pii: 10.1245/s10434-022-12283.
    >> Share

  137. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
    ASO Visual Abstract: Intervention for Hepatic and Pulmonary METastases in Breast Cancer Patients-Prospective, Multi-Institutional Registry Study: IMET; Protocol MF 14-02.
    Ann Surg Oncol. 2022 Aug 6. pii: 10.1245/s10434-022-12320.
    >> Share

  138. KLEMEN ND, Court CM, Fernandes MC, Walch HS, et al
    Local Therapy for Oligoprogression or Consolidation in High Mutational Burden Stage 4 Colorectal Cancer Treated With PD-1 or PD-L1 Blockade.
    Ann Surg Oncol. 2022 Aug 5. pii: 10.1245/s10434-022-12095.
    >> Share

    July 2022
  139. CHENG X, Zeng W, Liu Y, Song Z, et al
    Impact of Lymph Node Dissection on Survival and Tumor Recurrence for Patients with Resected cT1-2N0 Small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12215.
    >> Share

  140. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
    Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12239.
    >> Share

  141. BURCH AE, Wong JH, Irish WD
    ASO Author Reflections: Identifying and Understanding Disparities in Access to Surgery: Operable Lung Cancer in North Carolina.
    Ann Surg Oncol. 2022 Jul 12. pii: 10.1245/s10434-022-12179.
    >> Share

    June 2022
  142. USHITANI Y, Shimada Y, Yamada Y, Kudo Y, et al
    ASO Visual Abstract: Clinical Impact of Sarcopenia 1 Year after Surgery in Patients with Early-Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Jun 28. pii: 10.1245/s10434-022-12068.
    >> Share

  143. USHITANI Y, Shimada Y, Yamada Y, Kudo Y, et al
    Clinical Impact of Sarcopenia 1 Year After Surgery for Patients with Early-Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Jun 21. pii: 10.1245/s10434-022-11999.
    >> Share

  144. MATSUGUMA H, Mun M, Sano A, Yoshino I, et al
    Time to Incurable Recurrence for Patients Treated With Pulmonary Metastasectomy for Colorectal Cancer.
    Ann Surg Oncol. 2022 Jun 18. pii: 10.1245/s10434-022-11904.
    >> Share

  145. USHITANI Y, Shimada Y
    ASO Author Reflections: Management to Prevent Postoperative Sarcopenia in Patients with Lung Cancer.
    Ann Surg Oncol. 2022 Jun 14. pii: 10.1245/s10434-022-12026.
    >> Share

  146. BAILEY J, Van Haren RM
    Complementary Roles of Screening and Nodule Programs for Early Detection of Lung Cancer in Diverse Populations.
    Ann Surg Oncol. 2022 Jun 12. pii: 10.1245/s10434-022-11943.
    >> Share

  147. IWASAKI M, Ishihara S, Okada S, Shimegi R, et al
    ASO Visual Abstract: Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Jun 3. pii: 10.1245/s10434-022-11907.
    >> Share

  148. IWASAKI M, Ishihara S, Okada S, Shimegi R, et al
    Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Jun 2. pii: 10.1245/s10434-022-11835.
    >> Share

    May 2022
  149. DONINGTON JS
    Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer: Exciting New Horizon in Early-Stage Lung Cancer Care.
    Ann Surg Oncol. 2022 May 27. pii: 10.1245/s10434-022-11915.
    >> Share

  150. IWASAKI M, Ishihara S, Inoue M
    ASO Author Reflections: Clinical Significance of Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 May 25. pii: 10.1245/s10434-022-11886.
    >> Share

  151. KUO SW, Chen PH, Lu TP, Chen KC, et al
    ASO Visual Abstract: Primary Tumor Resection for Stage IV Non-Small-Cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.
    Ann Surg Oncol. 2022 May 15. pii: 10.1245/s10434-022-11687.
    >> Share

  152. KHAN TM, Verbus EA, Gandhi S, Heymach JV, et al
    Osimertinib, Surgery, and Radiation Therapy in Treating Patients with Stage IIIB or IV Non-Small Cell Lung Cancer with EGFR Mutations (NORTHSTAR).
    Ann Surg Oncol. 2022 May 9. pii: 10.1245/s10434-022-11627.
    >> Share

  153. TEKE ME, Sarvestani AL, Hernandez JM, Fernando HC, et al
    A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).
    Ann Surg Oncol. 2022 May 6. pii: 10.1245/s10434-022-11584.
    >> Share

  154. DONINGTON JS
    The Increasing Role of Surgery in Comprehensive Treatment of Advanced Non-small Cell Lung Cancer with Targetable Mutations.
    Ann Surg Oncol. 2022 May 6. pii: 10.1245/s10434-022-11764.
    >> Share

  155. DHANASOPON AP, Boffa DJ
    Defining Relevancy in Patient-Reported Outcomes for Lung Cancer Surgery.
    Ann Surg Oncol. 2022 May 3. pii: 10.1245/s10434-022-11797.
    >> Share

  156. YUN JK, Kim YH
    ASO Author Reflections: Could VAMLA be a Therapeutic Strategy in Selected Patients with Left-sided NSCLC?
    Ann Surg Oncol. 2022;29:2840-2841.
    >> Share

    April 2022
  157. KUO SW, Chen PH, Lu TP, Chen KC, et al
    Correction to: Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.
    Ann Surg Oncol. 2022 Apr 9. pii: 10.1245/s10434-022-11714.
    >> Share

  158. CUI C, Lian B, Zhang X, Wu D, et al
    An Evidence-Based Staging System for Mucosal Melanoma: A Proposal.
    Ann Surg Oncol. 2022 Apr 9. pii: 10.1245/s10434-022-11670.
    >> Share

    March 2022
  159. CHEN PH, Kuo SW, Chen JS
    ASO Author Reflection: Primary Tumor Resection for Stage IV Lung Cancer after Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor.
    Ann Surg Oncol. 2022 Mar 21. pii: 10.1245/s10434-022-11487.
    >> Share

  160. KUO SW, Chen PH, Lu TP, Chen KC, et al
    Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.
    Ann Surg Oncol. 2022 Mar 7. pii: 10.1245/s10434-022-11483.
    >> Share

  161. KEPENEKIAN V, Peron J, You B, Bonnefoy I, et al
    Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study.
    Ann Surg Oncol. 2022;29:2104-2113.
    >> Share

  162. KEPENEKIAN V, Peron J, You B, Glehen O, et al
    ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection.
    Ann Surg Oncol. 2022;29:2114-2115.
    >> Share

    February 2022
  163. WANKHEDE D, Grover S
    ASO Visual Abstract: Outcomes Following Curative Metastasectomy for Patients with Malignant Melanoma: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022 Feb 21. pii: 10.1245/s10434-022-11391.
    >> Share

  164. WANG ZN, Jiang XB, Lu J, Guo XY, et al
    Survival Benefit from Surgical Resection in Lung Cancer Patients with Brain Metastases: a Single-Center, Propensity-Matched Analysis Cohort Study.
    Ann Surg Oncol. 2022 Feb 18. pii: 10.1245/s10434-022-11365.
    >> Share

  165. LIU C, Wang W, Mei J, Zhu Y, et al
    Uniportal Thoracoscopic Single-Direction Basal Subsegmentectomy (Left S10a+ci): Trans-Inferior-Pulmonary-Ligament Approach.
    Ann Surg Oncol. 2022;29:1389-1391.
    >> Share

    January 2022
  166. KRUMEICH LN, Roses RE, Kuo LE, Lindeman BM, et al
    ASO Visual Abstract: Survival After Adrenalectomy for Metastatic Lung Cancer.
    Ann Surg Oncol. 2022 Jan 29. pii: 10.1245/s10434-021-11282.
    >> Share

  167. YUN JK, Yoo S, Lee GD, Choi S, et al
    Comparison of Long-Term Outcomes Between Minimally Invasive Pulmonary Resection With and Without Video-Assisted Mediastinoscopic Lymphadenectomy for Left-Sided Lung Cancer.
    Ann Surg Oncol. 2022 Jan 13. pii: 10.1245/s10434-021-11191.
    >> Share

  168. SUN C, Anraku M, Kawahara T, Karasaki T, et al
    Combination of Skeletal Muscle Mass and Density Predicts Postoperative Complications and Survival of Patients With Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Jan 8. pii: 10.1245/s10434-021-11024.
    >> Share

  169. LEECH MM, Weiss JE, Markey C, Loehrer AP, et al
    Influence of Race, Insurance, Rurality, and Socioeconomic Status on Equity of Lung and Colorectal Cancer Care.
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11160.
    >> Share

  170. KRUMEICH LN, Roses RE, Kuo LE, Lindeman BM, et al
    Survival After Adrenalectomy for Metastatic Lung Cancer.
    Ann Surg Oncol. 2022 Jan 6. pii: 10.1245/s10434-021-11192.
    >> Share

  171. KARUSH JM
    Segmentectomy...Because We Can or Because We Should?
    Ann Surg Oncol. 2022;29:28-29.
    >> Share

  172. DAI W, Mu Y, Chang S, Wu Z, et al
    ASO Author Reflections: Using Patient-Reported Outcomes to Compare Thoracoscopic Segmentectomy and Lobectomy.
    Ann Surg Oncol. 2022;29:557-558.
    >> Share

  173. LI Z, He W, Wang C
    ASO Author Reflections: A Simple Method to Predict Risk Factors of Complications After Pneumonectomy.
    Ann Surg Oncol. 2022;29:570-571.
    >> Share

    December 2021
  174. HANDA Y, Tsutani Y, Okada M
    ASO Author Reflection: Position of the Complex Segmentectomy on Postoperative Pulmonary Function.
    Ann Surg Oncol. 2021;28:8356-8357.
    >> Share

  175. HANDA Y, Tsutani Y, Mimae T, Miyata Y, et al
    Postoperative Pulmonary Function After Complex Segmentectomy.
    Ann Surg Oncol. 2021;28:8347-8355.
    >> Share

  176. CHIANG XH, Lu TP, Hsieh MS, Tsai TM, et al
    Thoracoscopic Wedge Resection Versus Segmentectomy for cT1N0 Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:8398-8411.
    >> Share

  177. LEE G, Yoon S, Ahn B, Kim HR, et al
    ASO Visual Abstract: Blood Vessel Invasion Predicts Postoperative Survival Outcomes and Systemic Recurrence Regardless of Location or Blood Vessel Type in Patients with Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28.
    >> Share

  178. CHIANG XH, Lu TP, Hsieh MS, Tsai TM, et al
    ASO Visual Abstract: Thoracoscopic Wedge Resection Versus Segmentectomy for cT1N0 Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28.
    >> Share

  179. ZHAO ZR, Liu DH, Wang YZ, Sun XS, et al
    ASO Visual Abstract: Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
    Ann Surg Oncol. 2021;28.
    >> Share

  180. SHIGEFUKU S
    Reply to "Ground Glass Opacity (GGO) Predicts Improved Survival of Pathologic Stage I Lung Adenocarcinoma Patients" by Guowei Che et al.
    Ann Surg Oncol. 2021;28.
    >> Share

  181. WANG Y, Che G
    Ground Glass Opacity (GGO) Predicts Improved Survival of Pathologic Stage I Lung Adenocarcinoma Patients.
    Ann Surg Oncol. 2021;28.
    >> Share

    November 2021
  182. SUN C, Anraku M, Nakajima J
    ASO Author Reflections: An Evolving Skeletal Muscle Profiling-Towards Precise Host Phenotype and Prognostic Stratification in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11025.
    >> Share

  183. SUN C, Anraku M, Kawahara T, Karasaki T, et al
    ASO Visual Abstract: Combination of Skeletal Muscle Mass and Density Predicts Postoperative Complications and Survival of Patients with Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11071.
    >> Share

  184. VAN JOOLINGEN WH, Rasing MJA, Peters M, van Lindert ASR, et al
    ASO Visual Abstract: Non-small Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection-can Chemoradiotherapy Offer Similar Survival?
    Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11061.
    >> Share

  185. JOHANSON H, Okereke I
    The Importance of Clinical Decision-Making in Surgical Planning for Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Nov 8. pii: 10.1245/s10434-021-11027.
    >> Share

  186. DAI W, Chang S, Pompili C, Qiu B, et al
    Early Postoperative Patient-Reported Outcomes After Thoracoscopic Segmentectomy Versus Lobectomy for Small-Sized Peripheral Non-small-cell Lung Cancer.
    Ann Surg Oncol. 2021 Nov 6. pii: 10.1245/s10434-021-10946.
    >> Share

  187. LEE G, Yoon S, Ahn B, Kim HR, et al
    Blood Vessel Invasion Predicts Postoperative Survival Outcomes and Systemic Recurrence Regardless of Location or Blood Vessel Type in Patients with Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:7279-7290.
    >> Share

  188. SUGARBAKER PH
    ASO Author Reflections: Normothermic Intraperitoneal Chemotherapy Long-Term for Malignant Peritoneal Mesothelioma.
    Ann Surg Oncol. 2021;28:7118-7119.
    >> Share

  189. MIMAE T, Saji H, Okada M
    ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?
    Ann Surg Oncol. 2021;28:7228-7229.
    >> Share

    October 2021
  190. VAN JOOLINGEN WH, Rasing MJA, Peters M, van Lindert ASR, et al
    Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?
    Ann Surg Oncol. 2021 Oct 30. pii: 10.1245/s10434-021-10982.
    >> Share

  191. DAI W, Chang S, Pompili C, Qiu B, et al
    ASO Visual Abstract: Early Postoperative Patient-Reported Outcomes After Thoracoscopic Segmentectomy Versus Lobectomy for Small-Sized Peripheral Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Oct 23. pii: 10.1245/s10434-021-10963.
    >> Share

  192. HANDA Y, Tsutani Y, Okada M
    Reply to "Lobe-Specific Lymph Node Dissection for Lung Cancer: Is It Still Feasible?" by Han-Yu Deng.
    Ann Surg Oncol. 2021 Oct 9. pii: 10.1245/s10434-021-10684.
    >> Share

  193. SHI Y, Wu S, Ma S, Lyu Y, et al
    Comparison Between Wedge Resection and Lobectomy/Segmentectomy for Early-Stage Non-small Cell Lung Cancer: A Bayesian Meta-analysis and Systematic Review.
    Ann Surg Oncol. 2021 Oct 6. pii: 10.1245/s10434-021-10857.
    >> Share

  194. ZHU Y, Xia L, Liu C, Lin F, et al
    Uniportal Single-Direction Thoracoscopic Right S9 Segmentectomy: Trans-Inferior-Pulmonary-Ligament Approach.
    Ann Surg Oncol. 2021;28:6407.
    >> Share

  195. NISHINO T, Toba H, Yoshida T, Inoue S, et al
    Endobronchial Ultrasound Improves the Diagnosis of the Tracheobronchial Invasion of Advanced Esophageal Cancer.
    Ann Surg Oncol. 2021;28:6398-6406.
    >> Share

  196. LEPPELMANN KS, Levesque VM, Bunck AC, Cahalane AM, et al
    Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study.
    Ann Surg Oncol. 2021;28:5829-5839.
    >> Share

  197. LI S, Qiao S, Li N, Zhu X, et al
    MiR-744 Functions as an Oncogene Through Direct Binding to c-Fos Promoter and Facilitates Non-small Cell Lung Cancer Progression.
    Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10688.
    >> Share

  198. LEPPELMANN KS, Fintelmann FJ
    ASO Author Reflections: Percutaneous Image-Guided Ablation and Multi-modality Management of Lung Metastases.
    Ann Surg Oncol. 2021;28:5840-5841.
    >> Share

    September 2021
  199. WEI X, Yu H, Dai W, Mu Y, et al
    Correction to: Patient-Reported Outcomes of Video-Assisted Thoracoscopic Surgery Versus Thoracotomy for Locally Advanced Lung Cancer: A Longitudinal Cohort Study.
    Ann Surg Oncol. 2021 Sep 24. pii: 10.1245/s10434-021-10798.
    >> Share

  200. HANDA Y, Tsutani Y, Okada M
    ASO Author Reflections: Survival Outcomes between Patients with Hypermetabolic Non-small Cell Lung Cancer Undergoing Systematic and Lobe-Specific Mediastinal Lymph Node Dissection.
    Ann Surg Oncol. 2021 Sep 3. pii: 10.1245/s10434-021-10037.
    >> Share

    August 2021
  201. DENG HY
    Lobe-Specific Lymph Node Dissection for Lung Cancer: Is it Still Feasible?
    Ann Surg Oncol. 2021 Aug 21. pii: 10.1245/s10434-021-10671.
    >> Share

  202. WANG C, Wang S, Li Z, He W, et al
    ASO Visual Abstract: A Multiple-Center Nomogram to Predict Pneumonectomy Complication Risk for Non-small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2021 Aug 3. pii: 10.1245/s10434-021-10542.
    >> Share

  203. ZHAO ZR, Liu DH, Wang YZ, Sun XS, et al
    Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
    Ann Surg Oncol. 2021;28:4542-4550.
    >> Share

  204. ZHAO ZR, Long H
    ASO Author Reflections: Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
    Ann Surg Oncol. 2021;28:4551-4552.
    >> Share

    July 2021
  205. WANG C, Wang S, Li Z, He W, et al
    A Multiple-Center Nomogram to Predict Pneumonectomy Complication Risk for Non-Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2021 Jul 28. pii: 10.1245/s10434-021-10504.
    >> Share

  206. HANDA Y, Tsutani Y, Mimae T, Miyata Y, et al
    Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer.
    Ann Surg Oncol. 2021 Jul 3. pii: 10.1245/s10434-021-10020.
    >> Share

  207. FU X, Wang F, Su X, Luo G, et al
    Endobronchial Ultrasound Improves Evaluation of Recurrent Laryngeal Nerve Lymph Nodes in Esophageal Squamous Cell Carcinoma Patients.
    Ann Surg Oncol. 2021;28:3930-3938.
    >> Share

  208. KIM IA, Hur JY, Kim HJ, Park JH, et al
    Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:3983-3993.
    >> Share

  209. KIM IA, Kim WS, Lee KY
    ASO Author Reflections: CTNNB1 and Fusion Genes as Predictors for Recurrence in Resected Early-Stage Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:3994-3995.
    >> Share

    June 2021
  210. CHIANG XH, Lin MW, Hsu HH, Chen JS, et al
    ASO Author Reflection: Comparing Wedge Resection and Segmentectomy as the Appropriate Surgical Method in cT1N0 Lung Cancer.
    Ann Surg Oncol. 2021 Jun 5. pii: 10.1245/s10434-021-10214.
    >> Share

  211. NAKAMURA A, Kondo N, Nakamichi T, Hashimoto M, et al
    Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma.
    Ann Surg Oncol. 2021;28:3057-3065.
    >> Share

  212. MATSUBARA T, Okamoto T
    ASO Author Reflections: The C-Reactive Protein (CRP)-Albumin Ratio May Be Useful as the Most Prognostic Index Among the Immuno-nutritional Parameters Using CRP and Albumin for Resected NSCLC.
    Ann Surg Oncol. 2021;28:3055-3056.
    >> Share

    May 2021
  213. WEI X, Yu H, Shi Q
    ASO Author Reflections: Using Patient-Reported Outcomes to Evaluate Surgical Approaches for Locally Advanced Lung Cancer.
    Ann Surg Oncol. 2021 May 15. pii: 10.1245/s10434-021-10018.
    >> Share

  214. LOTZE MT, Dhupar R
    ASO Author Reflection: Viruses, the Lung, and Thoracic Neoplasms: Breaking Bad.
    Ann Surg Oncol. 2021;28:2728-2729.
    >> Share

    April 2021
  215. MIMAE T, Saji H, Nakamura H, Okumura N, et al
    Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303.
    Ann Surg Oncol. 2021 Apr 26. pii: 10.1245/s10434-021-09835.
    >> Share

  216. WEI X, Yu H, Dai W, Mu Y, et al
    Patient-Reported Outcomes of Video-Assisted Thoracoscopic Surgery Versus Thoracotomy for Locally Advanced Lung Cancer: A Longitudinal Cohort Study.
    Ann Surg Oncol. 2021 Apr 20. pii: 10.1245/s10434-021-09981.
    >> Share

  217. GOOSEMAN MR, Brunelli A
    Intraoperative Lymph Node Management During Non-small Cell Lung Cancer Surgery.
    Ann Surg Oncol. 2021 Apr 16. pii: 10.1245/s10434-021-10039.
    >> Share

  218. KANTOR T, Wakeam E
    Landmark Trials in the Surgical Management of Mesothelioma.
    Ann Surg Oncol. 2021;28:2037-2047.
    >> Share

  219. CHEN D, Ding Q, Wang W, Wang X, et al
    Characterization of Extracapsular Lymph Node Involvement and Its Clinicopathological Characteristics in Stage II-IIIA Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:2088-2098.
    >> Share

  220. KAGIMOTO A, Tsutani Y, Okada M
    ASO Author Reflections: Usefulness of Visual Evaluation of PET in Predicting Prognosis after Lung Resection for Early-Stage Lung Adenocarcinoma and Selecting Candidates for Sublobar Resection.
    Ann Surg Oncol. 2021;28:2076-2077.
    >> Share

  221. KAGIMOTO A, Tsutani Y, Handa Y, Mimae T, et al
    Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:2068-2075.
    >> Share

    February 2021
  222. BATCHELOR T, Hasan J, Macbeth F, Shackcloth M, et al
    Randomised Controlled Trial Evidence Questions the Assumption that Pulmonary Metastasectomy Benefits Patients with Colorectal Cancer.
    Ann Surg Oncol. 2021 Feb 15. pii: 10.1245/s10434-020-09521.
    >> Share

  223. VAN VEENENDAAL LM, Bertolli E, Korse CM, Klop WMC, et al
    The Clinical Utility of Neuron-Specific Enolase (NSE) Serum Levels as a Biomarker for Merkel Cell Carcinoma (MCC).
    Ann Surg Oncol. 2021;28:1019-1028.
    >> Share

    January 2021
  224. SHIGEFUKU S, Shimada Y
    ASO Author Reflections: Impact of Ground-Glass Opacity Components in Long-Term Survivors with Resected Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:157-158.
    >> Share

  225. OHTSUKA T
    Importance of Ground-Glass Opacity in Long-Term Survivors of Lung Adenocarcinoma: A Leopard Cannot Change Its Spots.
    Ann Surg Oncol. 2021;28:14-15.
    >> Share

    October 2020
  226. DEMMY TL
    The Musician, Instrument, or Orchestra?
    Ann Surg Oncol. 2020;27:4088-4090.
    >> Share

  227. JUNG W, Cho S
    ASO Author Reflections: Understanding Subsolid Lung Adenocarcinoma with Cystic Airspaces (LACA).
    Ann Surg Oncol. 2020;27:4404.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016